Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

US Stock Market Move | 2027 fiscal year revenue guidance strong, Oracle Corporation (ORCL.US) opens with a major increase of over 13%

The first open-source AI intelligent body in the country! Youdao Inc ADR Class A(DAO.US) lobster: safe and controllable, easy to use and easy to get started.

TJCD(02515) issued a profit warning, with an estimated shareholder loss of 46 million to 51 million yuan in 2025.
US Stock Market Move | 2027 fiscal year revenue guidance strong, Oracle Corporation (ORCL.US) opens with a major increase of over 13%

The first open-source AI intelligent body in the country! Youdao Inc ADR Class A(DAO.US) lobster: safe and controllable, easy to use and easy to get started.

TJCD(02515) issued a profit warning, with an estimated shareholder loss of 46 million to 51 million yuan in 2025.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


